Infliximab in refractory spondyloarthropathies: a multicentre 38 week open study.
Collantes-Estévez
E
E
Muñoz-Villanueva
M C
MC
Cañete-Crespillo
J D
JD
Sanmartí-Sala
R
R
Gratacós-Masmitjá
J
J
Zarco-Montejo
P
P
Torre-Alonso
J C
JC
González-Fernández
C
C
D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D004351:Drug Resistance; D005260:Female; D006801:Humans; D000069285:Infliximab; D008297:Male; D011446:Prospective Studies; D025242:Spondylarthropathies / Q000188:drug therapy*; D013904:Thoracic Vertebrae
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D000069285:Infliximab